Histogram
Visit (Number) vs PM Diastolic Blood Presure 2nd Measurement
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Baseline (BL) | - | - | - | - | - | - | 1,516 | 1,516 |
Clinical Evaluation (CE) | - | - | - | - | - | - | 1,516 | 1,516 |
Diagnostic Visit (DX) | 1,232 | 76.8 | ± 13.8 | 78.0 | -2.0 | 120.0 | 284 | 1,516 |
CPAP Titration Visit (CPAP) | 1,056 | 75.8 | ± 15.0 | 78.0 | -1.0 | 130.0 | 460 | 1,516 |
Two Month Post-CPAP Neurocognitive Visit (2M) | 879 | 75.8 | ± 14.2 | 78.0 | -1.0 | 151.0 | 637 | 1,516 |
Four Month Post-CPAP Neurocognitive Visit (4M) | 833 | 9.2 | ± 28.1 | -2.0 | -2.0 | 122.0 | 683 | 1,516 |
Six Month Post-CPAP Neurocognitive Visit (6M) | 851 | 74.8 | ± 16.2 | 77.0 | -3.0 | 112.0 | 665 | 1,516 |
Gender vs PM Diastolic Blood Presure 2nd Measurement
Baseline (BL)
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | - | - | - | - | - | - | 1,516 | 1,516 |
Male | - | - | - | - | - | - | 958 | 958 |
Female | - | - | - | - | - | - | 558 | 558 |
Gender vs PM Diastolic Blood Presure 2nd Measurement
Clinical Evaluation (CE)
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | - | - | - | - | - | - | 1,516 | 1,516 |
Male | - | - | - | - | - | - | 958 | 958 |
Female | - | - | - | - | - | - | 558 | 558 |
Gender vs PM Diastolic Blood Presure 2nd Measurement
Diagnostic Visit (DX)
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 1,232 | 76.8 | ± 13.8 | 78.0 | -2.0 | 120.0 | 284 | 1,516 |
Male | 788 | 77.9 | ± 13.0 | 80.0 | -1.0 | 120.0 | 170 | 958 |
Female | 444 | 74.8 | ± 14.9 | 76.0 | -2.0 | 114.0 | 114 | 558 |
Gender vs PM Diastolic Blood Presure 2nd Measurement
CPAP Titration Visit (CPAP)
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 1,056 | 75.8 | ± 15.0 | 78.0 | -1.0 | 130.0 | 460 | 1,516 |
Male | 693 | 76.8 | ± 14.2 | 78.0 | -1.0 | 130.0 | 265 | 958 |
Female | 363 | 73.9 | ± 16.3 | 76.0 | -1.0 | 118.0 | 195 | 558 |
Gender vs PM Diastolic Blood Presure 2nd Measurement
Two Month Post-CPAP Neurocognitive Visit (2M)
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 879 | 75.8 | ± 14.2 | 78.0 | -1.0 | 151.0 | 637 | 1,516 |
Male | 572 | 76.5 | ± 14.4 | 78.0 | -1.0 | 151.0 | 386 | 958 |
Female | 307 | 74.6 | ± 13.8 | 76.0 | -1.0 | 108.0 | 251 | 558 |
Gender vs PM Diastolic Blood Presure 2nd Measurement
Four Month Post-CPAP Neurocognitive Visit (4M)
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 833 | 9.2 | ± 28.1 | -2.0 | -2.0 | 122.0 | 683 | 1,516 |
Male | 541 | 9.3 | ± 28.5 | -2.0 | -2.0 | 122.0 | 417 | 958 |
Female | 292 | 9.0 | ± 27.3 | -2.0 | -2.0 | 104.0 | 266 | 558 |
Gender vs PM Diastolic Blood Presure 2nd Measurement
Six Month Post-CPAP Neurocognitive Visit (6M)
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 851 | 74.8 | ± 16.2 | 77.0 | -3.0 | 112.0 | 665 | 1,516 |
Male | 552 | 75.6 | ± 15.8 | 78.0 | -2.0 | 112.0 | 406 | 958 |
Female | 299 | 73.2 | ± 16.7 | 75.0 | -3.0 | 104.0 | 259 | 558 |
Race/Ethnicity vs PM Diastolic Blood Presure 2nd Measurement
Baseline (BL)
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | - | - | - | - | - | - | 1,516 | 1,516 |
Native American | - | - | - | - | - | - | 28 | 28 |
Asian | - | - | - | - | - | - | 89 | 89 |
Black | - | - | - | - | - | - | 172 | 172 |
Hispanic | - | - | - | - | - | - | 116 | 116 |
White | - | - | - | - | - | - | 1,102 | 1,102 |
Other | - | - | - | - | - | - | 9 | 9 |
Race/Ethnicity vs PM Diastolic Blood Presure 2nd Measurement
Clinical Evaluation (CE)
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | - | - | - | - | - | - | 1,516 | 1,516 |
Native American | - | - | - | - | - | - | 28 | 28 |
Asian | - | - | - | - | - | - | 89 | 89 |
Black | - | - | - | - | - | - | 172 | 172 |
Hispanic | - | - | - | - | - | - | 116 | 116 |
White | - | - | - | - | - | - | 1,102 | 1,102 |
Other | - | - | - | - | - | - | 9 | 9 |
Race/Ethnicity vs PM Diastolic Blood Presure 2nd Measurement
Diagnostic Visit (DX)
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 1,232 | 76.8 | ± 13.8 | 78.0 | -2.0 | 120.0 | 284 | 1,516 |
Native American | 20 | 76.8 | ± 12.9 | 75.0 | 60.0 | 118.0 | 8 | 28 |
Asian | 74 | 75.0 | ± 13.4 | 77.0 | -1.0 | 108.0 | 15 | 89 |
Black | 120 | 79.1 | ± 15.4 | 80.0 | -1.0 | 120.0 | 52 | 172 |
Hispanic | 84 | 78.6 | ± 8.9 | 80.0 | 60.0 | 98.0 | 32 | 116 |
White | 926 | 76.5 | ± 13.7 | 78.0 | -2.0 | 114.0 | 176 | 1,102 |
Other | 8 | 73.0 | ± 31.4 | 79.0 | -1.0 | 96.0 | 1 | 9 |
Race/Ethnicity vs PM Diastolic Blood Presure 2nd Measurement
CPAP Titration Visit (CPAP)
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 1,056 | 75.8 | ± 15.0 | 78.0 | -1.0 | 130.0 | 460 | 1,516 |
Native American | 16 | 84.0 | ± 18.4 | 81.0 | 60.0 | 120.0 | 12 | 28 |
Asian | 58 | 73.3 | ± 13.4 | 76.0 | -1.0 | 108.0 | 31 | 89 |
Black | 96 | 79.5 | ± 16.5 | 80.0 | -1.0 | 130.0 | 76 | 172 |
Hispanic | 73 | 78.7 | ± 7.9 | 80.0 | 62.0 | 96.0 | 43 | 116 |
White | 808 | 75.0 | ± 15.2 | 78.0 | -1.0 | 120.0 | 294 | 1,102 |
Other | 5 | 84.2 | ± 12.3 | 85.0 | 64.0 | 94.0 | 4 | 9 |
Race/Ethnicity vs PM Diastolic Blood Presure 2nd Measurement
Two Month Post-CPAP Neurocognitive Visit (2M)
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 879 | 75.8 | ± 14.2 | 78.0 | -1.0 | 151.0 | 637 | 1,516 |
Native American | 13 | 79.3 | ± 28.3 | 88.0 | -1.0 | 114.0 | 15 | 28 |
Asian | 49 | 73.6 | ± 9.1 | 74.0 | 54.0 | 94.0 | 40 | 89 |
Black | 77 | 80.4 | ± 9.5 | 80.0 | 60.0 | 108.0 | 95 | 172 |
Hispanic | 65 | 74.8 | ± 16.0 | 78.0 | -1.0 | 94.0 | 51 | 116 |
White | 672 | 75.4 | ± 14.3 | 78.0 | -1.0 | 151.0 | 430 | 1,102 |
Other | 3 | 87.3 | ± 7.0 | 88.0 | 80.0 | 94.0 | 6 | 9 |
Race/Ethnicity vs PM Diastolic Blood Presure 2nd Measurement
Four Month Post-CPAP Neurocognitive Visit (4M)
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 833 | 9.2 | ± 28.1 | -2.0 | -2.0 | 122.0 | 683 | 1,516 |
Native American | 10 | 4.2 | ± 19.6 | -2.0 | -2.0 | 60.0 | 18 | 28 |
Asian | 47 | 8.0 | ± 26.6 | -2.0 | -2.0 | 92.0 | 42 | 89 |
Black | 73 | 7.7 | ± 28.3 | -2.0 | -2.0 | 122.0 | 99 | 172 |
Hispanic | 57 | 4.2 | ± 19.9 | -2.0 | -2.0 | 78.0 | 59 | 116 |
White | 643 | 10.0 | ± 29.0 | -2.0 | -2.0 | 104.0 | 459 | 1,102 |
Other | 3 | -2.0 | ± 0.0 | -2.0 | -2.0 | -2.0 | 6 | 9 |
Race/Ethnicity vs PM Diastolic Blood Presure 2nd Measurement
Six Month Post-CPAP Neurocognitive Visit (6M)
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 851 | 74.8 | ± 16.2 | 77.0 | -3.0 | 112.0 | 665 | 1,516 |
Native American | 13 | 65.2 | ± 39.5 | 76.0 | -1.0 | 110.0 | 15 | 28 |
Asian | 50 | 73.0 | ± 14.0 | 74.0 | -1.0 | 100.0 | 39 | 89 |
Black | 75 | 76.2 | ± 21.2 | 80.0 | -1.0 | 110.0 | 97 | 172 |
Hispanic | 61 | 75.5 | ± 15.9 | 78.0 | -1.0 | 100.0 | 55 | 116 |
White | 649 | 74.8 | ± 14.9 | 76.0 | -3.0 | 112.0 | 453 | 1,102 |
Other | 3 | 86.7 | ± 6.1 | 88.0 | 80.0 | 92.0 | 6 | 9 |